![]() |
International Business Machines Corporation (IBM) DCF Valuation |

Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
International Business Machines Corporation (IBM) Bundle
Gain mastery over your International Business Machines Corporation (IBM) valuation analysis with our state-of-the-art DCF Calculator! Preloaded with real (IBM) data, this Excel template enables you to adjust forecasts and assumptions to accurately determine the intrinsic value of International Business Machines Corporation (IBM).
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 55,179.0 | 57,351.0 | 60,530.0 | 61,860.0 | 62,753.0 | 64,811.3 | 66,937.2 | 69,132.7 | 71,400.3 | 73,742.3 |
Revenue Growth, % | 0 | 3.94 | 5.54 | 2.2 | 1.44 | 3.28 | 3.28 | 3.28 | 3.28 | 3.28 |
EBITDA | 10,555.0 | 12,409.0 | 7,174.0 | 14,693.0 | 12,176.0 | 12,414.3 | 12,821.5 | 13,242.0 | 13,676.4 | 14,125.0 |
EBITDA, % | 19.13 | 21.64 | 11.85 | 23.75 | 19.4 | 19.15 | 19.15 | 19.15 | 19.15 | 19.15 |
Depreciation | 6,695.0 | 6,417.0 | 4,802.0 | 4,396.0 | 4,667.0 | 5,936.6 | 6,131.3 | 6,332.4 | 6,540.1 | 6,754.6 |
Depreciation, % | 12.13 | 11.19 | 7.93 | 7.11 | 7.44 | 9.16 | 9.16 | 9.16 | 9.16 | 9.16 |
EBIT | 3,860.0 | 5,992.0 | 2,372.0 | 10,297.0 | 7,509.0 | 6,477.7 | 6,690.2 | 6,909.6 | 7,136.3 | 7,370.3 |
EBIT, % | 7 | 10.45 | 3.92 | 16.65 | 11.97 | 9.99 | 9.99 | 9.99 | 9.99 | 9.99 |
Total Cash | 13,812.0 | 7,250.0 | 8,738.0 | 13,441.0 | 14,591.0 | 12,584.8 | 12,997.6 | 13,423.9 | 13,864.2 | 14,319.0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 6,215.0 | 7,225.0 | 7,005.0 | 7,719.0 | 6,804.0 | 7,615.9 | 7,865.7 | 8,123.7 | 8,390.2 | 8,665.4 |
Account Receivables, % | 11.26 | 12.6 | 11.57 | 12.48 | 10.84 | 11.75 | 11.75 | 11.75 | 11.75 | 11.75 |
Inventories | 1,839.0 | 1,649.0 | 1,552.0 | 1,161.0 | 1,289.0 | 1,646.6 | 1,700.6 | 1,756.4 | 1,814.0 | 1,873.5 |
Inventories, % | 3.33 | 2.88 | 2.56 | 1.88 | 2.05 | 2.54 | 2.54 | 2.54 | 2.54 | 2.54 |
Accounts Payable | 4,033.0 | 3,955.0 | 4,051.0 | 4,132.0 | 4,032.0 | 4,407.5 | 4,552.0 | 4,701.4 | 4,855.6 | 5,014.8 |
Accounts Payable, % | 7.31 | 6.9 | 6.69 | 6.68 | 6.43 | 6.8 | 6.8 | 6.8 | 6.8 | 6.8 |
Capital Expenditure | -3,042.0 | -2,381.0 | -1,860.0 | -1,810.0 | -1,685.0 | -2,378.4 | -2,456.4 | -2,537.0 | -2,620.2 | -2,706.1 |
Capital Expenditure, % | -5.51 | -4.15 | -3.07 | -2.93 | -2.69 | -3.67 | -3.67 | -3.67 | -3.67 | -3.67 |
Tax Rate, % | -3.9 | -3.9 | -3.9 | -3.9 | -3.9 | -3.9 | -3.9 | -3.9 | -3.9 | -3.9 |
EBITAT | 8,389.3 | 7,113.1 | 3,365.1 | 8,889.3 | 7,801.7 | 6,300.6 | 6,507.3 | 6,720.7 | 6,941.2 | 7,168.8 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | 8,021.3 | 10,251.1 | 6,720.1 | 11,233.3 | 11,470.7 | 9,064.8 | 10,022.9 | 10,351.7 | 10,691.2 | 11,041.9 |
WACC, % | 6.62 | 6.62 | 6.62 | 6.5 | 6.62 | 6.6 | 6.6 | 6.6 | 6.6 | 6.6 |
PV UFCF | ||||||||||
SUM PV UFCF | 42,173.6 | |||||||||
Long Term Growth Rate, % | 4.00 | |||||||||
Free cash flow (T + 1) | 11,484 | |||||||||
Terminal Value | 442,169 | |||||||||
Present Terminal Value | 321,263 | |||||||||
Enterprise Value | 363,437 | |||||||||
Net Debt | 44,449 | |||||||||
Equity Value | 318,988 | |||||||||
Diluted Shares Outstanding, MM | 937 | |||||||||
Equity Value Per Share | 340.36 |
What You Will Get
- Real IBM Financials: Access historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed automatically.
- Scenario Analysis: Evaluate various scenarios to assess IBM’s future performance.
- User-Friendly Design: Designed for professionals while remaining accessible to newcomers.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation frameworks.
- WACC Calculator: Ready-to-use Weighted Average Cost of Capital template with adjustable parameters.
- Customizable Forecast Assumptions: Edit growth projections, capital investments, and discount rates.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios for International Business Machines Corporation (IBM).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis.
How It Works
- Download: Access the ready-to-use Excel file featuring IBM’s financial data.
- Customize: Tailor forecasts, including revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate multiple projections and instantly compare results.
- Make Decisions: Utilize the valuation outcomes to inform your investment strategy.
Why Choose This Calculator for IBM (IBM)?
- Precision: Utilizes authentic IBM financials for reliable data accuracy.
- Versatility: Tailored for users to experiment with and adjust inputs effortlessly.
- Efficiency: Avoid the complexities of constructing a DCF model from the ground up.
- Expert-Level: Crafted with the precision and usability expected by finance professionals.
- Intuitive: Simple to navigate, even for those lacking extensive financial modeling skills.
Who Should Use This Product?
- Investors: Evaluate IBM’s valuation prior to making stock transactions.
- CFOs and Financial Analysts: Enhance valuation methodologies and assess financial forecasts.
- Startup Founders: Understand how large public entities like IBM are appraised.
- Consultants: Provide detailed valuation reports for clients in need.
- Students and Educators: Utilize real-world data to learn and instruct on valuation practices.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for IBM (IBM).
- Real-World Data: IBM’s historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into IBM’s performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to IBM (IBM).
- Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results regarding IBM (IBM).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.